Cochrane Abstracts
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431171/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients.
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431171/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients. Accessed January 20, 2026.
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431171/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients
Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431171/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
ID - 431171
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431171/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
